SMTL ID : 5fto.1

Crystal structure of the ALK kinase domain in complex with Entrectinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.22 Å

Oligo State

monomer

Ligands

1 x YMX: Entrectinib(Non-covalent)

YMX.1: 19 residues within 4Å: Chain A: L.30, G.31, F.35, V.38, A.56, L.104, E.105, L.106, M.107, A.108, G.109, G.110, D.111, R.161, N.162, C.163, L.164, G.177, D.178 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.30, A:F.35, A:F.35, A:V.38, A:V.38, A:L.104, A:L.164, A:L.164 Hydrogen bonds: A:E.105, A:M.107, A:M.107 Salt bridges: A:E.118

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Menichincheri, M. et al., Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (Alk), C-Ros Oncogene 1 Kinase (Ros1), and Pan-Tropomyosin Receptor Kinases (Pan-Trks) Inhibitor. J.Med.Chem. (2016)

Release Date

2016-04-06

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence